Weight-loss drugs may help curb binge eating when paired with therapy

NCT ID NCT07042672

First seen Jun 26, 2026 ยท Last updated Jun 26, 2026

Summary

This study looks at whether adding GLP-1 weight-loss drugs to cognitive behavioral therapy helps adults with severe obesity and binge eating disorder. About 80 participants will either take a GLP-1 drug or not, while both groups attend therapy sessions. Researchers will track changes in binge eating symptoms, weight, and harmful coping behaviors over 12 months.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
GLP-1 receptor agonists (liraglutide, semaglutide, or tirzepatide)
What this could lead to
If successful, this could show that combining GLP-1 drugs with behavioral therapy improves control of binge eating and weight more than therapy alone.
What could go wrong
This is a small, non-randomized observational study, so results may not prove cause and effect. GLP-1 drugs can cause side effects like nausea and are not a standalone cure for binge eating.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BINGE EATING DISORDER ASSOCIATED WITH OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

binge eating disorder Binge-Eating Disorder eating disorder Feeding and Eating Disorders Obesity obesity disorder Overweight

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Haukeland University Hospital

    RECRUITING

    Bergen, Vestland, 5021, Norway

More trials for these conditions

Other studies related to the condition(s) this trial covers.